The current level of evidence is too scarce to draw any conclusions regarding the role of nodal disease in patients with POLE mutation, and further studies are needed to demonstrate any correlation between conventional risk factors and molecular/genomic characterization of endometrial tumors. The gene discussed is POLE; the disease is endometrium neoplasm.